News & Events category:
All news stories abut COVID-19 research taking place at MFT
Manchester doctors play leading role in ‘breakthrough’ COVID-19 drug research
Manchester doctors have played a leading role in global coronavirus research, which has found the first drug shown to increase survival rates in people hospitalised with COVID-19.
Greater Manchester children take part in voluntary coronavirus antibody research – ‘What’s the STORY’
A research study evaluating the presence of COVID-19 antibodies in children and young people is taking place at ourTrust.
First MFT patient receives drug ‘Anakinra’ under COVID-19 trial SCIL-1Ra
A Wythenshawe Hospital patient with COVID-19 is the first Manchester University NHS Foundation Trust recruit to a clinical trial investigating the drug Anakinra to treat COVID-19.
Children of Manchester researchers join COVID-19 antibody study
Many MFT staff members are involving their children in our vitally important COVID-19 research, with some of them sharing their experiences.
More than 600 Greater Manchester school children and teachers participate in national research monitoring prevalence of COVID-19
More than 600 school children and teachers in Greater Manchester have taken part in a new voluntary coronavirus study, which is assessing the prevalence of COVID-19 in school pupils and teachers.
First MFT patient takes part in adaptive COVID-19 trial – ‘ACCORD 2’
Our first patient has taken part in a new clinical trial investigating potential treatments for COVID-19, as part of a nationwide research effort to meet the challenge of coronavirus.
Manchester researchers lead national programme to assess instant testing for COVID-19
Researchers from Manchester University NHS Foundation Trust and The University of Manchester are to assess the effectiveness of tests that may give doctors COVID-19 results in minutes rather than days
First adult MFT research participant receives donated plasma from recovered COVID-19 patient
Our first adult patient has received transfusion of blood plasma from a donor who has recovered from coronavirus (COVID-19), as part of a clinical trial looking at potential treatments for the virus.